Short answer
Wave Life Sciences Ltd. (WVE) filed an 8-K current report with the SEC on February 26, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure). Q4 and full-year 2025 earnings announced Feb 26, 2026.
Wave Life Sciences Ltd. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Q4 and full-year 2025 earnings announced Feb 26, 2026
- Full financial results in Exhibit 99.1: press release contains key figures for investor review
Item 7.01 · Regulation FD Disclosure
- Corporate presentation updated Feb 26, 2026: available on IR website and filed as Exhibit 99.2
- Reg FD disclosure ensures all investors receive simultaneous access to company strategy/pipeline updates
- Furnished (not filed): limits legal liability but signals material business updates worth reviewing directly
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Wave Life Sciences Ltd. 8-K filings
Get the next WVE 8-K as it lands
Follow WVE for push alerts, or ask the research agent what this filing means.